Tochigi Ontario Holdings | Archived Press

Tochigi Ontario Holdings has today said that US-based speciality chemicals production company Platform Speciality Corporation has agreed to acquire Arysta LifeScience for $3.51 bn, including debt.   “The terms of the agreement to purchase Arysta LifeScience is a cash and stock deal. Platform Speciality will pay $2.91 billion in cash and $600 million in stock to Arysta’s private equity stock owner Permira” said Jonathan Turner, Head of Corporate Trading at Tochigi Ontario Holdings. “Platform Speciality Corporation, earlier valued at $3.35 billion on Monday, will double its size,” he added.    Tochigi Ontario Holdings says Platform Specialty will acquire Arysta for $3.5 billion The company was co-founded by Martin E Franklin last year out of a shell company. On completion of the deal, Franklin will own 20% of the stock in Platform Speciality Corporation. The company specializes in the production of chemicals used in oil drilling industries, electronics, and automotive. It h...